Stemline Therapeutics, Inc. (STML) Financial Statements (2024 and earlier)

Company Profile

Business Address 750 LEXINGTON AVENUE
NEW YORK, NY 10022
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2020
MRQ
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 164,43160,10651,72046,87946,03953,983
Cash and cash equivalents 13,5629,4444,79510,31613,37625,007
Short-term investments 150,86950,66246,92536,56332,66328,976
Receivables 15,120     
Inventory, net of allowances, customer advances and progress billings 1,151     
Inventory 1,151     
Prepaid expense 1406944485247
Deferred costs   144   
Deposits current assets 556189  106106
Other undisclosed current assets 3,7632,6952812434941,484
Total current assets: 185,16163,05952,18947,17046,69155,620
Noncurrent Assets
Property, plant and equipment 1912221372396230
Long-term investments and receivables   14,46820,71551,4294,645
Long-term investments   14,46820,71551,4294,645
Other noncurrent assets 309212212212  
Other undisclosed noncurrent assets 1,318     
Total noncurrent assets: 1,81843514,81720,94951,5244,875
TOTAL ASSETS: 186,97963,49467,00668,11998,21660,495
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 21,95221,15319,7429,2859,4556,171
Employee-related liabilities 5,5995,5152,9401,975 1,697
Accrued liabilities 4216871,9615179,4554,474
Other undisclosed accounts payable and accrued liabilities 15,93314,95114,8416,793  
Deferred revenue and credits 898 486
Other liabilities 10669771  
Other undisclosed current liabilities 1,170    (2,182)
Total current liabilities: 23,13221,21919,83910,2549,4554,474
Noncurrent Liabilities
Liabilities, other than long-term debt 47397142648608
Deferred revenue and credits  617608
Other liabilities 4739714231 
Other undisclosed noncurrent liabilities 226     
Total noncurrent liabilities: 2317397142648608
Total liabilities: 23,36321,29219,93610,39610,1045,082
Equity
Equity, attributable to parent 163,61642,20247,07057,72388,11255,413
Common stock 533221
Additional paid in capital 529,488331,343251,490193,564185,703115,605
Accumulated other comprehensive income (loss) 28(57)(146)(100)(154)3
Accumulated deficit (365,905)(289,088)(204,276)(135,743)(97,440)(60,196)
Total equity: 163,61642,20247,07057,72388,11255,413
TOTAL LIABILITIES AND EQUITY: 186,97963,49467,00668,11998,21660,495

Income Statement (P&L) ($ in thousands)

3/31/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues  5008981,041654335
Revenue, net8981,041654335
Cost of revenue
(Cost of Goods and Services Sold)
 (4,893)     
Gross profit: (4,893)5008981,041654335
Operating expenses (117,571)(86,787)(69,457)(39,927)(38,288)(29,325)
Other undisclosed operating income 43,217     
Operating loss: (79,248)(86,287)(68,558)(38,885)(37,633)(28,990)
Nonoperating income 2,4911,263730557388156
Investment income, nonoperating 2,5381,271736546386153
Interest and debt expense (35)(1)    
Loss from continuing operations before income taxes: (76,792)(85,024)(67,828)(38,328)(37,245)(28,833)
Income tax benefit 2615,6563,4022521,39016,568
Loss from continuing operations: (76,766)(69,369)(64,426)(38,303)(15,856)(12,265)
Loss before gain (loss) on sale of properties: (76,766)(69,369)(64,426)(38,303)(15,856)(12,265)
Other undisclosed net loss (51)(15,656)(3,402)   
Net loss attributable to parent: (76,817)(85,024)(67,828)(38,303)(15,856)(12,265)
Other undisclosed net loss available to common stockholders, basic     (21,388)(16,565)
Net loss available to common stockholders, diluted: (76,817)(85,024)(67,828)(38,303)(37,244)(28,830)

Comprehensive Income ($ in thousands)

3/31/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss: (76,817)(85,024)(67,828)(38,303)(15,856)(12,265)
Comprehensive loss: (76,817)(85,024)(67,828)(38,303)(15,856)(12,265)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 8589(46)54(21,545)(16,518)
Comprehensive loss, net of tax, attributable to parent: (76,732)(84,935)(67,875)(38,249)(37,401)(28,783)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: